209 related articles for article (PubMed ID: 16343992)
21. Selection of self-reactive peptides within human aggrecan by use of a HLA-DRB1*0401 peptide binding motif.
Boots AM; Verheijden GF; Schöningh R; van Staveren CJ; Bos E; Elewaut D; de Keyser F; Veys E; Joosten I; Rijnders AW
J Autoimmun; 1997 Dec; 10(6):569-78. PubMed ID: 9451596
[TBL] [Abstract][Full Text] [Related]
22. Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells.
Zhao J; Li R; He J; Shi J; Long L; Li Z
Rheumatol Int; 2008 Nov; 29(1):9-16. PubMed ID: 18600328
[TBL] [Abstract][Full Text] [Related]
23. 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl)ethyl]propenamide (Z23), an effective compound from the Chinese herb medicine Fissistigma oldhamii (Hemsl.) Merr, suppresses T cell-mediated immunity in vitro and in vivo.
Hu XD; Zhong XG; Zhang XH; Zhang YN; Zheng ZP; Zhou Y; Tang W; Yang Y; Yang YF; Hu LH; Zuo JP
Life Sci; 2007 Dec; 81(25-26):1677-84. PubMed ID: 18022200
[TBL] [Abstract][Full Text] [Related]
24. Degenerate recognition and response of human CD4+ Th cell clones: implications for basic and applied immunology.
Nishimura Y; Chen YZ; Uemura Y; Tanaka Y; Tsukamoto H; Kanai T; Yokomizo H; Yun C; Matsuoka T; Irie A; Matsushita S
Mol Immunol; 2004 Feb; 40(14-15):1089-94. PubMed ID: 15036913
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between HLA-DR4/1 subtypes and T cell response to influenza virus hemagglutinin or anti-HA308-317 antibodies in rheumatoid arthritis].
Li X; Li R; Li ZG
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1881-3. PubMed ID: 19039998
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of T-cell activation with HLA-DR1/DR4 restricted Non-T-cell stimulating peptides.
Zhou Q; Cheng Y; Lü H; Zhou W; Li Z
Hum Immunol; 2003 Sep; 64(9):857-65. PubMed ID: 12941540
[TBL] [Abstract][Full Text] [Related]
27. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
[TBL] [Abstract][Full Text] [Related]
28. Anti-Human type II collagen CD19+ B cells are present in patients with rheumatoid arthritis and healthy individuals.
He X; Kang AH; Stuart JM
J Rheumatol; 2001 Oct; 28(10):2168-75. PubMed ID: 11669151
[TBL] [Abstract][Full Text] [Related]
29. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.
Srinivasan M; Eri R; Zunt SL; Summerlin DJ; Brand DD; Blum JS
Arthritis Rheum; 2007 Feb; 56(2):498-508. PubMed ID: 17265485
[TBL] [Abstract][Full Text] [Related]
30. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
[TBL] [Abstract][Full Text] [Related]
31. Structure-immune response relationships of hapten-modified collagen II peptides in a T-cell model of allergic contact dermatitis.
Holmdahl M; Ahlfors SR; Holmdahl R; Hansson C
Chem Res Toxicol; 2008 Aug; 21(8):1514-23. PubMed ID: 18616296
[TBL] [Abstract][Full Text] [Related]
32. [Impact of citrullination upon antigenicity of fibrinogen].
Zhao Y; Tian X; Li ZG
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):628-32. PubMed ID: 20450789
[TBL] [Abstract][Full Text] [Related]
33. APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients.
Barberá A; Lorenzo N; Garrido G; Mazola Y; Falcón V; Torres AM; Hernández MI; Hernández MV; Margry B; de Groot AM; van Roon J; van der Zee R; Broere F; van Eden W; Padrón G; Domínguez Mdel C
Int Immunopharmacol; 2013 Dec; 17(4):1075-83. PubMed ID: 24177275
[TBL] [Abstract][Full Text] [Related]
34. Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis.
Shen Z; Chen L; Liu YF; Gao TW; Wang G; Fan XL; Fan JY; Fan PS; Li CY; Liu B; Dang YP; Li CX
J Am Acad Dermatol; 2006 Jun; 54(6):992-1002. PubMed ID: 16713453
[TBL] [Abstract][Full Text] [Related]
35. Altered influenza virus haemagglutinin peptides inhibit T cell responses to type II collagen in rheumatoid arthritis.
Li X; Li R; Li Z
Ann Rheum Dis; 2005 Dec; 64(12):1790-1. PubMed ID: 16284345
[No Abstract] [Full Text] [Related]
36. Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes.
Xu L; Liu Y; He X
Cell Mol Immunol; 2005 Aug; 2(4):295-300. PubMed ID: 16274628
[TBL] [Abstract][Full Text] [Related]
37. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
Mullazehi M; Mathsson L; Lampa J; Rönnelid J
Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
[TBL] [Abstract][Full Text] [Related]
38. Identification of small-molecule inhibitors against human leukocyte antigen-death receptor 4 (HLA-DR4) through a comprehensive strategy.
Liu Z; Li B; Li X; Zhang L; Lai L
J Chem Inf Model; 2011 Feb; 51(2):326-34. PubMed ID: 21284404
[TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
40. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
